Tuesday, November 10, 2026 · 3:00 PM
Building 46, 43 Vassar Street, Cambridge, MA
See tickets
Alan Mardinly and Murat Günel lead a seminar exploring how biohybrid implants could replace electric fields with chemical neurotransmitters to treat Parkinson's disease. The talk addresses current hurdles in opsin sensitivity, gene delivery, and immunogenicity that have kept optogenetics out of clinical use so far. Join the discussion at Seminar Room 3189 in Building 46 on Tuesday, November 10, 2026.